Neos Therapeutics, Inc. (NASDAQ:NEOS) resubmits ADHD drug marketing application

Neos Therapeutics, Inc. (NASDAQ:NEOS) said it resubmitted the marketing application for its attention deficit/hyperactivity disorder (ADHD) drug to the U.S. Food and Drug Administration. The company said last year the FDA had identified deficiencies that precluded discussion of labeling and marketing requirements for the company’s treatment of a common type of behavioral disorder.

On last trading day, Neos Therapeutics, Inc. (NASDAQ:NEOS) traded 386110 shares and was closed at $5.85 per share. Company stock is -61.51% away from its one year high and is moving 10.38% ahead of its one year low. Stock monthly performance is recorded as -17.61% while its performance in last one week is -3.31%. NEOS quarterly performance is -11.09% while firm’s price to sale ratio is 12.37 and price to book ratio is 5.91.

Analyst’s Analysis on Neos Therapeutics, Inc. (NASDAQ:NEOS)
Number of analysts are eying on this stock and after detailed observation, they have given the stock mean target price of $19.75 while their mean recommendation is 1.80 (1=Buy, 5=sell). The consensus recommendation by Thomson Reuters analysts is Outperform and their mean rating for the stock is 1.60 on scale of 1-5.

Tim Brown, CEO and president of the global design consultancy IDEO, will join the Steelcase Inc. (NYSE:SCS) Board of Directors, effective today. Brown’s experience as an industrial designer, business leader, philanthropist and author will bring additional experience and perspective to the board.

Steelcase Inc. (NYSE:SCS) shares moved to $17.90 after starting the day at $17.90 on Friday. The weekly volatility of SCS is 1.96% and monthly volatility is 3.25%. Its weekly performance is 1.13% while year to date (YTD) performance is 24.22%.

What Analysts Say About Steelcase Inc. (NYSE:SCS)
Stock has got outperform rating from no analyst of Thomson Reuters whereas 2 analysts given hold rating to the stock. Analyst’s mean target price for the firm is $17.00 while analysts mean recommendation is 2.30.

On last trading day, The Kraft Heinz Company (NASDAQ:KHC) traded 2.05 Million shares and was closed at $87.32 per share. Company stock is -2.86% away from its one year high and is moving 31.73% ahead of its one year low. Stock monthly performance is recorded as 6.94% while its performance in last one week is 0.05%. KHC quarterly performance is -1.74% while firm’s price to sale ratio is 3.98 and price to book ratio is 1.84.

Analyst’s Analysis on The Kraft Heinz Company (NASDAQ:KHC)
Number of analysts are eying on this stock, and after detailed observation, they have given the stock mean target price of $90.29 while their mean recommendation is 2.70 (1=Buy, 5=sell). The consensus recommendation by Thomson Reuters Analysts is Outperform for KHC and their mean rating for the stock is 2.06 on scale of 1-5.

Nordstrom, Inc. (NYSE:JWN) shares moved to $47.93 after starting the day at $48.44 on Friday. The weekly volatility of JWN is 2.25% and monthly volatility is 3.19%. Firm weekly performance is -0.64% while year to date (YTD) performance is -0.82%. Company net profit margin stands at 2.30% whereas its Gross Margin is 35.60%. This year company’s Earnings per Share (EPS) growth is -15.10% and next year’s estimated EPS growth is 6.52%.

What Analysts Say About Nordstrom, Inc. (NYSE:JWN)
Stock has got outperform rating from 3 analysts of Thomson Reuters whereas 16 analysts given hold rating to the stock. Analyst’s mean target price for JWN is $54.06 while analysts mean recommendation is 2.90.

Leave a Reply

Your email address will not be published. Required fields are marked *